Mississippi Health System Buckles Under ‘Astounding’ Rise in COVID-19 Cases
Compared with the first half of July, the number of infections more than doubled in the past two weeks and deaths rose by 51 percent
CDC Now Says Vaccinated Should Be Tested After COVID-19 Exposure, Even Without Symptoms
Even though fully vaccinated people may still get infected, infections tend to have mild or no symptoms
FDA Approves First Biosimilar Insulin Product
Semglee (insulin glargine-yfgn) is biosimilar to and interchangeable with Lantus (insulin glargine), provides cost-effective option
Cognitive Impairment Reported After COVID-19 Infection
Cognitive impairment identified in cohort of older Amerindians and in 32 patients after mild-to-moderate COVID-19
Long-Term Complications Common With Youth-Onset T2DM
Risk factors for development of complications include minority race or ethnic group, hyperglycemia, hypertension, dyslipidemia
Global Dementia Cases Projected to Top 152 Million in 2050
Increases in cases mainly due to population growth and aging, with relative importance of these factors varying by region
CT Findings Tied to Prognosis in Mild Traumatic Brain Injury
Certain pathological CT features associated with adverse outcomes up to one year after mild traumatic brain injury
Sickle Cell Disease May Up Risk for Poor COVID-19 Outcomes
Sickle cell trait also associated with increased risk for COVID-19-related hospitalization and death, but to a lesser extent
Metabolic Syndrome Linked to Increased Risk for Stroke Recurrence
Low levels of HDL cholesterol and having two or more components of metabolic syndrome predict recurrence
Most With Reaction to mRNA COVID-19 Vaccine Tolerate Second Dose
Most patients with immediate, potentially allergic reaction to Pfizer-BioNTech or Moderna mRNA COVID-19 vaccine tolerate second dose
